Catherine Sulawske-guck - Net Worth and Insider Trading

Catherine Sulawske-guck Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Catherine Sulawske-guck owns 1 companies in total, including US Stem Cell Inc (USRM) .

Click here to see the complete history of Catherine Sulawske-guck’s form 4 insider trades.

Insider Ownership Summary of Catherine Sulawske-guck

Ticker Comapny Transaction Date Type of Owner
USRM US Stem Cell Inc 2007-10-02 VP of Admin & HR

Catherine Sulawske-guck Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Catherine Sulawske-guck Ownership Network

Ownership Network List of Catherine Sulawske-guck

No Data

Ownership Network Relation of Catherine Sulawske-guck

Insider Network Chart

Catherine Sulawske-guck Owned Company Details

What does US Stem Cell Inc do?

Who are the key executives at US Stem Cell Inc?

Catherine Sulawske-guck is the VP of Admin & HR of US Stem Cell Inc. Other key executives at US Stem Cell Inc include Chief Science Officer Kristin C Comella , Vice President,Sales&Marketing Matthew J Fendrich , and VP of Financial Operations Nicholas M Burke .

US Stem Cell Inc (USRM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of US Stem Cell Inc (USRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of US Stem Cell Inc (USRM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

US Stem Cell Inc (USRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

US Stem Cell Inc Insider Transactions

No Available Data

Catherine Sulawske-guck Mailing Address

Above is the net worth, insider trading, and ownership report for Catherine Sulawske-guck. You might contact Catherine Sulawske-guck via mailing address: 13794 Nw 4th Street, Suite 212, Sunrise Fl 33325.

Discussions on Catherine Sulawske-guck

No discussions yet.